Subscribe To
AMED / Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
![Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review](https://cdn.snapi.dev/images/v1/j/y/image-1447289800-2139093.jpg)
AMED News
![Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review](https://cdn.snapi.dev/images/v1/j/y/image-1447289800-2139093.jpg)
By Seeking Alpha
November 3, 2023
Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
Amedisys, Inc. is set to be acquired by UnitedHealth Group in a $3.29 billion merger agreement. Some US legislators have called for further scrutiny o more_horizontal
![Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say](https://cdn.snapi.dev/images/v1/8/a/default31-2118965.jpg)
By Zacks Investment Research
October 24, 2023
Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2023, it might be worth con more_horizontal
![Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates](https://cdn.snapi.dev/images/v1/d/x/default31-2118895.jpg)
By Zacks Investment Research
October 24, 2023
Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates
Amedisys (AMED) came out with quarterly earnings of $0.98 per share, missing the Zacks Consensus Estimate of $1.08 per share. This compares to earning more_horizontal
![Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year? Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?](https://cdn.snapi.dev/images/v1/h/i/default13-2109267.jpg)
By Zacks Investment Research
October 18, 2023
Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
Here is how Amedisys (AMED) and Cybin Inc. (CYBN) have performed compared to their sector so far this year. more_horizontal
![Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip](https://cdn.snapi.dev/images/v1/9/2/35723-1995078.jpg)
By Zacks Investment Research
July 28, 2023
Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip
Strength in Hugh Acuity Care segment and Hospice division drive Amedisys (AMED) Q2 performance. more_horizontal
![Amedisys (AMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates Amedisys (AMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates](https://cdn.snapi.dev/images/v1/8/w/default15-1990986.jpg)
By Zacks Investment Research
July 26, 2023
Amedisys (AMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended June 2023, it could be wort more_horizontal
![UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems](https://cdn.snapi.dev/images/v1/a/m/amedisys-1-457x274-1948739.jpg)
By PYMNTS
June 26, 2023
UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems
In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday, more_horizontal
![UnitedHealth Buys Amedisys for $3.3 Billion UnitedHealth Buys Amedisys for $3.3 Billion](https://cdn.snapi.dev/images/v1/r/g/gettyimages-1419167348-ba893f2cc74a4e0984ff615851b5cc9f-1948371.jpg)
By Investopedia
June 26, 2023
UnitedHealth Buys Amedisys for $3.3 Billion
UnitedHealth Group outbid Option Care's offer to buy home healthcare provider Amedisys. more_horizontal